Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOFIBER-DAMINO A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.1% 7.1%   Bankruptcy risk   0.7% 1.8% 0.6% 0.6% 3.8% 2.4% 8.9% 8.9%   Credit score (0-100)   94 73 98 95 51 62 28 28   Credit rating   AA A AA AA BBB BBB BB BB   Credit limit (kDKK)   1,017.1 5.2 1,082.4 1,193.7 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   15,240 14,258 14,231 14,916 8,620 10,038 0.0 0.0   EBITDA   800 -772 1,308 1,815 -4,768 -1,302 0.0 0.0   EBIT   800 -772 1,308 1,815 -4,768 -1,302 0.0 0.0   Pre-tax profit (PTP)   339.4 -1,266.4 868.7 1,483.1 -5,343.6 -2,224.1 0.0 0.0   Net earnings   262.4 -1,008.8 675.1 1,154.2 -4,168.4 -1,738.2 0.0 0.0   Pre-tax profit without non-rec. items   339 -1,266 869 1,483 -5,344 -2,224 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   12,067 10,952 9,823 9,492 9,107 8,827 0.0 0.0   Shareholders equity total   7,850 6,842 7,517 8,671 7,156 7,418 5,543 5,543   Interest-bearing liabilities   11,816 11,414 8,016 11,698 12,063 11,439 0.0 0.0   Balance sheet total (assets)   25,215 23,272 21,413 27,298 22,758 22,821 5,543 5,543   Net Debt   11,672 11,250 7,769 11,354 11,765 11,088 -5,543 -5,543     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   15,240 14,258 14,231 14,916 8,620 10,038 0.0 0.0   Gross profit growth   -7.2% -6.4% -0.2% 4.8% -42.2% 16.4% -100.0% 0.0%   Employees   30 28 28 27 27 26 0 0   Employee growth %   0.0% -6.7% 0.0% -3.6% 0.0% -3.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   25,215 23,272 21,413 27,298 22,758 22,821 5,543 5,543   Balance sheet change%   2.9% -7.7% -8.0% 27.5% -16.6% 0.3% -75.7% 0.0%   Added value   799.6 -772.1 1,307.8 1,815.1 -4,768.1 -1,301.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -127 -1,169 -1,113 -200 -263 -157 -11,376 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.2% -5.4% 9.2% 12.2% -55.3% -13.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.3% -3.1% 5.9% 7.6% -18.9% -5.6% 0.0% 0.0%   ROI %   3.9% -3.6% 7.1% 9.4% -22.6% -6.5% 0.0% 0.0%   ROE %   3.4% -13.7% 9.4% 14.3% -52.7% -23.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.1% 29.7% 35.1% 31.8% 31.4% 32.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,459.7% -1,457.1% 594.1% 625.5% -246.7% -851.9% 0.0% 0.0%   Gearing %   150.5% 166.8% 106.6% 134.9% 168.6% 154.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 4.4% 4.7% 3.7% 5.2% 8.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.5 0.4 0.4 0.2 0.3 0.0 0.0   Current Ratio   0.9 0.9 1.0 1.0 0.9 0.9 0.0 0.0   Cash and cash equivalent   144.0 163.8 246.6 344.0 298.5 351.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,111.0 -1,701.3 -238.0 490.2 -2,098.8 -2,086.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   27 -28 47 67 -177 -50 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   27 -28 47 67 -177 -50 0 0   EBIT / employee   27 -28 47 67 -177 -50 0 0   Net earnings / employee   9 -36 24 43 -154 -67 0 0